---
authors:
- Slawson, David C
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/37725472/
file_path: 2023/09/treat-to-target-ldl-strategy-of-statin-dosing-is-noninferior.md
issue: '3'
keywords:
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
last_updated: '2025-07-30'
mesh_terms:
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
original_format: PubMed
pages: Online
patient_population: Adults
peer_reviewed: true
pmid: '37725472'
processed_date: '2025-07-30'
publication_date: '2023-09-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-07-30'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Treat-to-Target LDL Strategy of Statin Dosing Is Noninferior to High-Intensity Dosing.
topics:
- Family Medicine
volume: '108'
---

# Treat-to-Target LDL Strategy of Statin Dosing Is Noninferior to High-Intensity Dosing.

**Authors:** Slawson, David C

**Published in:** American family physician | Vol. 108, No. 3 | 2023-09-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/37725472/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/37725472/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
